Screening for Lymphangioleiomyomatosis by High-Resolution Computed Tomography in Young, Nonsmoking Women Presenting with Spontaneous Pneumothorax Is Cost-Effective
- 15 June 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 181 (12) , 1376-1382
Abstract
Rationale: Women with pulmonary lymphangioleiomyomatosis (LAM) who present with a sentinel spontaneous pneumothorax (SPTX) will experience an average of 2.5 additional pneumothoraces. The diagnosis of LAM is typically delayed until after the second pneumothorax. Objectives: We hypothesized that targeted screening of an LAM-enriched population of nonsmoking women between the ages of 25 and 54 years, who present with a sentinel pneumothorax indicated by high-resolution computed tomography (HRCT), will facilitate early identification, definitive therapy, and improved quality of life for patients with LAM. Methods: We constructed a Markov state-transition model to assess the cost-effectiveness of screening. Rates of SPTX and prevalence of LAM in populations stratified by age, sex, and smoking status were derived from the literature. Costs of testing and treatment were extracted from 2007 Medicare data. We compared a strategy based on HRCT screening followed by pleurodesis for patients with LAM, versus no HRCT screening. Measurements and Main Results: The prevalence of LAM in nonsmoking women, between the ages of 25 and 54 years, with SPTX is estimated at 5% on the basis of the available literature. In our base case analysis, screening for LAM by HRCT is the most cost-effective strategy, with a marginal cost–effectiveness ratio of $32,980 per quality-adjusted life-year gained. Sensitivity analysis showed that HRCT screening remains cost-effective for groups in which the prevalence of LAM in the population subset screened is greater than 2.5%. Conclusions: Screening for LAM by HRCT in nonsmoking women age 25–54 that present with SPTX is cost-effective. Physicians are advised to screen for LAM by HRCT in this population.Keywords
This publication has 44 references indexed in Scilit:
- Lymphangioleiomyomatosis: A reviewEuropean Journal of Internal Medicine, 2008
- LymphangioleiomyomatosisChest, 2008
- LymphangioleiomyomatosisEuropean Respiratory Journal, 2006
- The NHLBI Lymphangioleiomyomatosis RegistryAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Lymphangioleiomyomatosis: Radiologic-Pathologic CorrelationRadioGraphics, 2005
- Non-Neurologic Manifestations of Tuberous Sclerosis ComplexJournal of Child Neurology, 2004
- Lymphangioleiomyomatosis: a review of the literatureRespiratory Medicine, 2002
- Prevalence and Clinical Characteristics of Lymphangioleiomyomatosis (LAM) in Patients with Tuberous Sclerosis ComplexAmerican Journal of Respiratory and Critical Care Medicine, 2001
- High Frequency of Pulmonary Lymphangioleiomyomatosis in Women With Tuberous Sclerosis ComplexMayo Clinic Proceedings, 2000
- Accuracy of high-resolution CT in diagnosing lung diseases.American Journal of Roentgenology, 1998